The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Nutrineal Solution for Peritoneal Dialysis 4 with 1.1% Amino Acids



Baxter Holding B.V.PA2299/016/001

Main Information

Trade NameNutrineal Solution for Peritoneal Dialysis 4 with 1.1% Amino Acids
Active SubstancesL-tyrosine
L-tryptophan
L-phenylalanine
L-threonine
L-serine
L-proline
Glycine
L-alanine
L-valine
L-methionine
L-isoleucine
L-leucine
L-lysine hydrochloride
L-histidine
L-arginine
Calcium chloride
Magnesium chloride
Sodium (S) - lactate
Sodium chloride
Dosage FormSolution for peritoneal dialysis
Licence HolderBaxter Holding B.V.
Licence NumberPA2299/016/001

Group Information

ATC CodeB05DB Hypertonic solutions

Status

License statusAuthorised
Licence Issued08/08/1994
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceSPECIAL CONDITIONS Conditions Parametric Release for Sterility approved on 21st December 2004 in accordance with CPMP/QWP/3015/00, Note for Guidance on Parametric Release and Annex 17 to the EU guide on Good Manufacturing Practice provided the following conditions apply: 1. The approval is valid only for the Baxter Healthcare SA, Breaffy Road, Castlebar, Co Mayo, Ireland and manufactured in Viaflex bags only. 2. No double sterilization cycle is covered by this variation. Therefore any cycle aborted prior to completion and subjected to a second sterilization cycle is not covered by this variation. 3. In accordance with European Pharmacopoeia general monograph on parenteral products, which includes the requirements that Parenteral products comply with the test for sterility, so the sterility test remains a requirement for all sterilised products even where parametric release is approved, and should therefore be retained in the finished product specifications even though not routinely conducted batch
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back